GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Electromed Inc (AMEX:ELMD) » Definitions » EBITDA

ELMD (Electromed) EBITDA : $9.22 Mil (TTM As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Electromed EBITDA?

Electromed's EBITDA for the three months ended in Sep. 2024 was $2.16 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was $9.22 Mil.

During the past 12 months, the average EBITDA Growth Rate of Electromed was 93.00% per year. During the past 3 years, the average EBITDA Growth Rate was 25.60% per year. During the past 5 years, the average EBITDA Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Electromed was 54.90% per year. The lowest was -25.80% per year. And the median was 6.50% per year.

Electromed's EBITDA per Share for the three months ended in Sep. 2024 was $0.24. Its EBITDA per share for the trailing twelve months (TTM) ended in Sep. 2024 was $1.03.

During the past 12 months, the average EBITDA per Share Growth Rate of Electromed was 88.30% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 25.70% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Electromed was 45.20% per year. The lowest was -32.80% per year. And the median was 5.15% per year.


Electromed EBITDA Historical Data

The historical data trend for Electromed's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Electromed EBITDA Chart

Electromed Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.86 3.75 3.60 4.62 7.42

Electromed Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 2.47 2.05 2.55 2.16

Competitive Comparison of Electromed's EBITDA

For the Medical Devices subindustry, Electromed's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Electromed's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromed's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Electromed's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Electromed's EBITDA for the fiscal year that ended in Jun. 2024 is calculated as

Electromed's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Jun. 2024, Electromed's EBITDA was $7.42 Mil.

Electromed's EBITDA for the quarter that ended in Sep. 2024 is calculated as

Electromed's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Sep. 2024, Electromed's EBITDA was $2.16 Mil.

EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Electromed  (AMEX:ELMD) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Electromed EBITDA Related Terms

Thank you for viewing the detailed overview of Electromed's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Electromed Business Description

Traded in Other Exchanges
N/A
Address
500 Sixth Avenue NW, New Prague, MN, USA, 56071
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
Executives
Andrew Summers director 601 JEFFERSON STREET, HOUSTON TX 77002
Kathleen Skarvan officer: Chief Executive Officer 40 WEST HIGHLAND PARK DR NE, HUTCHINSON MN 55350
James L. Cunniff director, officer: CEO and President 500 SIXTH AVE NW, NEW PRAGUE MN 56071
Bradley M. Nagel officer: Chief Financial Officer 500 SIXTH AVE NW, NEW PRAGUE MN 56071
Michelle C. Wirtz officer: Chief Financial Officer 500 SIXTH AVENUE NW,, NEW PRAGUE MN 56071
Christopher G. Holland officer: Chief Commercial Officer 500 SIXTH AVENUE NW, NEW PRAGUE MN 56071
Joseph L. Galatowitsch director 500 SIXTH AVENUE NW, NEW PRAGUE MN 56071
Kathleen A Tune director 60 SOUTH SIXTH STREET, SUITE 3620, MINNEAPOLIS MN 55402
A Jones Lee director 54 LOCKE LAKE RD, FRIDLEY MN 55432
Stephen H. Craney director 25340 SANDPIPER LANE, WINONA MN 55987
Andrea M. Walsh director 500 SIXTH AVENUE NW, NEW PRAGUE MN 56071
George H. Winn director 27451 COUNTRY HOLLOWS LANE, NEW PRAGUE MN 56701
Michael Joseph Maccourt officer: Chief Financial Officer 500 SIXTH AVENUE NW, NEW PRAGUE MN 56071
Gregory Fluet director 14405 21ST AVENUE NORTH, MINNEAPOLIS MN 55447
John L Erb director C/O VASCULAR SOLUTIONS, INC., 6464 SYCAMORE COURT N., MINNEAPOLIS, MN 55369

Electromed Headlines